Form of Proxy

Approval of the annual financial statements for the 2025 financial year

Approval of the consolidated financial statements of Crdit Agricole S.A. for the 2025 financial year

Approval of the consolidated financial statements of the Crdit Agricole Group for the 2025 financial year

Appropriation of net income for the 2025 financial year, declaration and payment of dividend

Approval of the Bforbank Shareholders' Agreement signed between the Company and SACAM Avenir

Approval of the Shareholders' Agreement of CA Sant et Territoires signed between the Company and SACAM SANTE ET TERRITOIRES

Approval of amendment no. 2 to the CAGIP shareholders' agreement signed between the Company, FNCA, CATS, CAAS, CA Consumer Finance, Crdit Agricole CIB, CAGS, CAPS and LCL

Approval of the tax consolidation agreement signed between the Company and the Crdit Agricole Regional Banks

Approval of tax consolidation agreements signed between the Company and SACAM Mutualisation, SAS Rue la Botie, SAS Sgur, SAS Miromesnil, SACAM Avenir, SACAM Dveloppement, SACAM International, SACAM Participations, SACAM Fia-Net Europe, SACAM Fireca, SACAM Immobilier, SACAM Machinisme, SACAM Assurance Caution, SARL Adicam, SAS Crdit Agricole Logemen

Approval of Group VAT agreements signed between the Company and the relevant Group companies

Approval of the Worldline share subscription letter and its amendment signed between the Company, Worldline and Delfinances

Approval of the CA-Immobilier Shareholders' Agreement signed between the Company and SACAM Immobilier

Appointment of Mr Marc Didier as Director to replace Mr Jean-Pierre Gaillard

Appointment of Mr Richard Belorgie as Director to replace Ms Nicole Gourmelon

Renewal of the term of office of Agns Audier, Director

Renewal of the term of office of Sonia Bonnet-Bernard, Director

Renewal of the term of office of Marie-Claire Daveu, Director

Renewal of the term of office of Alessia Mosca, Director

Renewal of the term of office of Galle Regnard, Director

Renewal of the term of office of Carol Sirou, Director

Renewal of the term of office of Pascal Lheureux, Director

Renewal of the term of office of Eric Vial, Director

Ratification of the co-optation of Franck Alexandre as Director, who replaced Dominique Lefebvre as of 1 January 2026

Approval of the compensation policy for Eric Vial, Chairman of the Board of Directors

Approval of the compensation policy for Olivier Gavalda, Chief Executive Officer

Approval of the compensation policy for Jrme Grivet, Deputy Chief Executive Officer

Approval of the compensation policy for the Directors

Approval of the components of the total compensation and benefits of any kind paid during the financial year ended 31 December 2025 or awarded for that financial year to Dominique Lefebvre, Chairman of the Board of Directors

Approval of the fixed, variable and exceptional components of the total compensation and benefits of any kind paid during the financial year ended 31 December 2025 or awarded for that financial year to Philippe Brassac, Chief Executive Officer, for the period from 1 January 2025 to the end of the General Meeting of 14 May 2025

Approval of the fixed, variable and exceptional components of?the total?compensation and benefits of any kind paid during the?financial?year ended 31 December 2025 or awarded for that financial year to Olivier Gavalda, Chief Executive Officer, from 14 May 2025 to the end of the General Meeting

Approval of the fixed, variable and exceptional components of the total compensation and benefits of any kind paid during the financial year ended 31 December 2025 or awarded for that financial year to Olivier Gavalda, Deputy Chief Executive Officer, for the period from 1 January 2025 to the end of the General Meeting on 14 May 2025

Approval of the fixed, variable and exceptional components of?the total?compensation and benefits of any kind paid during the?financial?year ended 31 December 2025 or awarded for that financial year to Jrme Grivet, Deputy Chief Executive Officer

Approval of the fixed, variable and exceptional components of total compensation and benefits of any kind paid during the financial year ended 31 December 2025 or awarded for that financial year to Xavier Musca, Deputy Chief Executive Officer, for the period from 1 January 2025 to the end of the General Meeting on 14 May 2025

Approval of the compensation report

Opinion on the overall amount of compensation paid during the past financial year to employee categories whose professional activities have a significant impact on the risk profile of the Company or Group, as referred to in Article L. 511-71 of the French Monetary and Financial Code

Authorisation to be granted to the Board of Directors to purchase the shares of the Company or cause them to be purchased

Delegation of authority to the Board of Directors to increase the share capital by issuing shares and/or securities giving immediate or future access to the capital of the Company or of another company, with pre-emptive subscription rights

Delegation of authority to the Board of Directors to increase the share capital by issuing shares and/or securities giving immediate or future access to the capital of the Company or of another company, without pre-emptive subscription rights, through offers to the public other than those referred to in Article L. 411-2 1 of the French Monetary and

Delegation of authority to the Board of Directors to increase the share capital by issuing shares and/or securities giving immediate or future access to the capital of the Company or of another company, without pre-emptive subscription rights, through offers to the public referred to in Article L. 411-2 1o of the French Monetary and Financial Code

Delegation of authority to the Board of Directors to increase the share capital by issuing shares and/or securities giving immediate or future access to the capital of the Company or of another company, without pre-emptive subscription rights, through offers to the public referred to in Article L. 411-2 1o of the French Monetary and Financial Code

Option to issue shares and/or securities giving immediate or future access to the capital, without pre-emptive subscription rights, in order to remunerate contributions in kind granted to the Company and consisting of equity securities or securities giving access to the capital, excluding public exchange offers

Delegation of authority to the Board of Directors to increase the share capital by issuing shares and/or securities giving immediate or future access to the capital of the Company or of another company, without pre-emptive subscription rights, reserved for one or more specifically designated persons

Delegation of authority to the Board of Directors to increase the amount of the initial issue, in?the?event of the issue of shares or securities giving immediate or future access to the share capital of the Company or of another company, with?or?without?pre-emptive subscription rights

Overall limit on authorisations to issue shares and share equivalents with or without pre-emptive subscription rights

Delegation of authority to be granted to the Board of Directors to increase the share capital by incorporation of reserves, profits, premiums or any other sums

Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing shares and/or securities, giving immediate or future access to the capital of the Company or of another company, without pre-emptive subscription rights, reserved for employees of Crdit Agricole Group companies participating in an employee savin

Delegation of authority to the Board of Directors to increase the share capital, without pre-emptive subscription rights, by issuing shares or securities giving immediate or future access to the capital of the Company or of another company, reserved for a category of beneficiaries, as part of an employee shareholding transaction

Authorisation to be granted to the Board of Directors to reduce the share capital through cancellation of shares

Authorisation to be granted to the Board of Directors to make free allocations of performance shares, existing or to be issued, to employees and corporate officers of the Group or to some of them

Powers to carry out formalities